Skip to content

Alan Anticevic

13 papers in the library · 1,427 citations · publishing 2012-2025

Papers

Sort Most recent Most cited

Neural mechanisms of psychedelic visual imagery.

Molecular Psychiatry April 1, 2025 Devon Stoliker, Katrin H. Preller, Leonardo Novelli et al. 19 citations

Visual alterations under classic psychedelics can include rich phenomenological accounts of eyes-closed imagery. Preclinical evidence suggests agonism of the 5-HT2A receptor may reduce synaptic gain to produce psychedelic-induced imagery. However, this has not been investigated in humans. To infer the directed connectivity changes to visual connectivity underlying psychedelic visual imagery in...

Correction: Neural mechanisms of psychedelic visual imagery.

Molecular Psychiatry April 1, 2025 Devon Stoliker, Katrin H. Preller, Leonardo Novelli et al. correction

In the sentence beginning ‘Connectivity from the EVA follows two broad pathways. The dorsal pathway is connected with the fusiform gyrus (FG), which is part of the inferior temporal cortex that functions to recognise objects and faces [45]. The ventral pathway from the EVA is connected to the intraparietal sulcus (IPS), which, along with the inferior frontal gyrus (IFG), is involved in...

Ketamine Alters Tuning of Neural and Behavioral Spatial Working Memory Precision

bioRxiv Preprint Server February 10, 2025 Masih Rahmati, Flora Moujaes, Nina Purg Suljič et al. 1 citation preprint

Deficits in working memory (WM) are a hallmark of neuropsy-chiatric disorders such as schizophrenia, yet their neurobiological basis remains poorly understood. Glutamate N-methyl-D-aspartate receptors (NMDARs) are critical for spatial WM (sWM), with NMDAR antagonist ketamine known to attenuate task-evoked activation and reduce sWM accuracy. Cortical microcircuit models hypothesize that NMDAR...

DOI: 10.1101/2025.02.10.637233 (opens in new tab) Full text (opens in new tab) Memory deficits:memory problems Poorer memory Memory impairment Memory loss +12

Ketamine induces multiple individually distinct whole-brain functional connectivity signatures.

Elife April 17, 2024 Flora Moujaes, Jie Lisa Ji, Masih Rahmati et al. 23 citations

Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it is unclear how ketamine's molecular mechanisms connect to its neural and behavioral effects. We conducted a single-blind placebo-controlled study, with participants blinded to their treatment condition....

DOI: 10.7554/elife.84173 (opens in new tab) Full text (opens in new tab) Data reduction FMRI Gene expression Human +5

Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging July 17, 2023 Flora Moujaes, Nathalie M. Rieser, Christophe Phillips et al. 19 citations

BACKGROUND: Pharmacological and nonpharmacological methods of inducing altered states of consciousness (ASCs) are becoming increasingly relevant in the treatment of psychiatric disorders. While comparisons between them are often drawn, to date no study has directly compared their neural correlates. METHODS: To address this knowledge gap, we directly compared 2 pharmacological methods...

The thalamus in psychosis spectrum disorder.

Frontiers in Neuroscience 2023 Alan Anticevic, Michael M. Halassa 41 citations

Psychosis spectrum disorder (PSD) affects 1% of the world population and results in a lifetime of chronic disability, causing devastating personal and economic consequences. Developing new treatments for PSD remains a challenge, particularly those that target its core cognitive deficits. A key barrier to progress is the tenuous link between the basic neurobiological understanding of PSD and its...

DOI: 10.3389/fnins.2023.1163600 (opens in new tab) Full text (opens in new tab) Cognition Computation Functional connectivity Pharmacology +4

Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans

Biological Psychiatry December 7, 2022 Flora Moujaes, Katrin H. Preller, Jie Lisa Ji et al. 44 citations

Precision psychiatry aims to identify markers of interindividual variability that allow for predicting the right treatment for each patient. However, bridging the gap between molecular-level manipulations and neural systems-level functional alterations remains an unsolved problem in psychiatry. After decades of low success rates in pharmaceutical research and development for psychiatric drugs,...

Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD

Elife July 12, 2021 Joshua B. Burt, Katrin H. Preller, Murat Demirtaş et al. 49 citations

Psychoactive drugs can transiently perturb brain physiology while preserving brain structure. The role of physiological state in shaping neural function can therefore be investigated through neuroimaging of pharmacologically induced effects. Previously, using pharmacological neuroimaging, we found that neural and experiential effects of lysergic acid diethylamide (LSD) are attributable to...

Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity

Biological Psychiatry January 13, 2020 Katrin H. Preller, Patricia Duerler, Joshua B. Burt et al. 199 citations

BackgroundThe use of psilocybin in scientific and experimental clinical contexts has triggered renewed interest in the mechanism of action of psychedelics. However, its time-dependent systems-level neurobiology remains sparsely investigated in humans.MethodsWe conducted a double-blind, randomized, counterbalanced, crossover study comprising 23 healthy human participants who received placebo and...

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

Elife October 25, 2018 Katrin H. Preller, Joshua B. Burt, Jie Lisa Ji et al. 416 citations

Background: Lysergic acid diethylamide (LSD) has agonist activity at various serotonin (5-HT) and dopamine receptors. Despite the therapeutic and scientific interest in LSD, specific receptor contributions to its neurobiological effects remain unknown. Methods: We therefore conducted a double-blind, randomized, counterbalanced, cross-over studyduring which 24 healthy human participants received...

DOI: 10.7554/elife.35082 (opens in new tab) Serotonin Ketanserin Neuropharmacology Agonist +2

Connectivity, Pharmacology, and Computation: Toward a Mechanistic Understanding of Neural System Dysfunction in Schizophrenia

Frontiers in Psychiatry 2013 Alan Anticevic, Michael W. Cole, Grega Repovš et al. 78 citations

Neuropsychiatric diseases such as schizophrenia and bipolar illness alter the structure and function of distributed neural networks. Functional neuroimaging tools have evolved sufficiently to reliably detect system-level disturbances in neural networks. This review focuses on recent findings in schizophrenia and bipolar illness using resting-state neuroimaging, an advantageous approach for...

Linking Microcircuit Dysfunction to Cognitive Impairment: Effects of Disinhibition Associated with Schizophrenia in a Cortical Working Memory Model

Cerebral Cortex November 29, 2012 John D. Murray, Alan Anticevic, Mark G. Gancsos et al. 278 citations

Excitation-inhibition balance (E/I balance) is a fundamental property of cortical microcircuitry. Disruption of E/I balance in prefrontal cortex is hypothesized to underlie cognitive deficits observed in neuropsychiatric illnesses such as schizophrenia. To elucidate the link between these phenomena, we incorporated synaptic disinhibition, via N-methyl-D-aspartate receptor perturbation on...

DOI: 10.1093/cercor/bhs370 (opens in new tab) Full text (opens in new tab) Disinhibition Working memory Prefrontal cortex Cognition +1

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia

Proceedings of the National Academy of Sciences September 25, 2012 Alan Anticevic, Mark G. Gancsos, John D. Murray et al. 260 citations

Glutamatergic neurotransmission mediated by N-methyl-d-aspartate (NMDA) receptors is vital for the cortical computations underlying cognition and might be disrupted in severe neuropsychiatric illnesses such as schizophrenia. Studies on this topic have been limited to processes in local circuits; however, cognition involves large-scale brain systems with multiple interacting regions. A prominent...

DOI: 10.1073/pnas.1208494109 (opens in new tab) Full text (opens in new tab) Nmda receptor Disinhibition Schizophrenia object-oriented programming Cognition +4